What the Research Says
Zeaxanthin evidence is closely tied to the AREDS2 trial (2013, JAMA), which validated the lutein/zeaxanthin combination as a safer and equally effective replacement for beta-carotene. The foveal concentration of zeaxanthin makes it particularly critical for central visual acuity. Epidemiological studies consistently link higher zeaxanthin intake with 30-40% lower AMD risk.
